QIAGEN acquires remaining stake in NeuMoDx Molecular for $248m
QIAGEN has completed the full acquisition following the receipt of the US regulatory clearance. (Credit: QIAGEN)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X